Contributions
Abstract: P1022
Type: Poster Sessions
Abstract Category: Clinical aspects of MS - Clinical assessment tools
Introduction: Patients with Multiple Sclerosis (MS) commonly have poor balance control, which causes their increased risk of falls and decreased quality of life. In the MS clinic, balance are poorly monitorized by subjective rating scales or traditional stopwatch-timed and metric tests such as Berg Balance Scale (BBS) and Timed Up and Go Test (TUG). However, researchers and clinicians require objective and quantitative measurement tools for asssesing balance in MS.
Objectives: To examine the validity of the Modified Clinical Test of Sensory Interaction and Balance Test (M-CTSIB) for patients with MS.
Methods: Thirty-nine ambulatory patients with MS (Expanded Disability Status Scale, EDSS 0-6.5) and 20 healthy controls performed M-CTSIB. MS group also performed BBS and TUG. M-CTSIB was assessed by Biodex-BioSwayTM (Biodex Inc., Shirley, New York). M-CTSIB investigates the relationship between balance and visual, somatosensory and vestibular system. Tests carried out were 4 conditions, condition-1: eyes open-firm surface, condition-2: eyes closed-firm surface, condition 3: eyes open-foam surface, and condition 4: eyes closed-foam surface, for 30 second intervals with two repetitions. High scores indicate high postural sway of the test subject.
Results: Patients with MS displayed higher postural sway compared with healthy controls on all conditions of M-CTSIB (p< 0.001). All components of M-CTSIB were negatively and significantly correlated with BBS (for condition-1: r=0.663, p< 0.001; for condition-2: r=0.657, p< 0.001; for condition-3: r=0.702, p< 0.001; for condition-4: r=0.740, p< 0.001). All components of M-CTSIB were positively and significantly correlated with TUG (for condition-1: r=0.705, p< 0.001; for condition-2: r=0.522, p=0.003; for condition-3: r=0.628, p< 0.001; for condition-4: r=0.742, p< 0.001).
Conclusions: M-CTSIB appears to be a clinically objective and available measurement for assessing balance in patients with MS. It has advantages including standardization, ease of administration and more challenging conditions such as when standing with eyes closed on foam surface.
Disclosure: "F. Söke: nothing to disclose"
"A. Güclü Gündüz: nothing to disclose"
"C. Ozkul: nothing to disclose"
"K. Cekim: nothing to disclose"
"C. Irkec: nothing to disclose"
Abstract: P1022
Type: Poster Sessions
Abstract Category: Clinical aspects of MS - Clinical assessment tools
Introduction: Patients with Multiple Sclerosis (MS) commonly have poor balance control, which causes their increased risk of falls and decreased quality of life. In the MS clinic, balance are poorly monitorized by subjective rating scales or traditional stopwatch-timed and metric tests such as Berg Balance Scale (BBS) and Timed Up and Go Test (TUG). However, researchers and clinicians require objective and quantitative measurement tools for asssesing balance in MS.
Objectives: To examine the validity of the Modified Clinical Test of Sensory Interaction and Balance Test (M-CTSIB) for patients with MS.
Methods: Thirty-nine ambulatory patients with MS (Expanded Disability Status Scale, EDSS 0-6.5) and 20 healthy controls performed M-CTSIB. MS group also performed BBS and TUG. M-CTSIB was assessed by Biodex-BioSwayTM (Biodex Inc., Shirley, New York). M-CTSIB investigates the relationship between balance and visual, somatosensory and vestibular system. Tests carried out were 4 conditions, condition-1: eyes open-firm surface, condition-2: eyes closed-firm surface, condition 3: eyes open-foam surface, and condition 4: eyes closed-foam surface, for 30 second intervals with two repetitions. High scores indicate high postural sway of the test subject.
Results: Patients with MS displayed higher postural sway compared with healthy controls on all conditions of M-CTSIB (p< 0.001). All components of M-CTSIB were negatively and significantly correlated with BBS (for condition-1: r=0.663, p< 0.001; for condition-2: r=0.657, p< 0.001; for condition-3: r=0.702, p< 0.001; for condition-4: r=0.740, p< 0.001). All components of M-CTSIB were positively and significantly correlated with TUG (for condition-1: r=0.705, p< 0.001; for condition-2: r=0.522, p=0.003; for condition-3: r=0.628, p< 0.001; for condition-4: r=0.742, p< 0.001).
Conclusions: M-CTSIB appears to be a clinically objective and available measurement for assessing balance in patients with MS. It has advantages including standardization, ease of administration and more challenging conditions such as when standing with eyes closed on foam surface.
Disclosure: "F. Söke: nothing to disclose"
"A. Güclü Gündüz: nothing to disclose"
"C. Ozkul: nothing to disclose"
"K. Cekim: nothing to disclose"
"C. Irkec: nothing to disclose"